Epstein Secrets

e Trial Ready To Analyze Shot's Effectiveness. Bloomberg (11/11, Langreth, 4.73M) reports that the "same US explosion of Covid-19 cases that helped Pfizer Inc. get results for its vaccine trial earlier this week is helping speed along Moderna's trial." Moderna "said Wednesday its study has accumulated more

ditional forms of open-source data. Sources for Bulletin Intelligence audience-size estimates include Scarborough, Gil( MRI, comScore, Nielsen, and the Audit Bureau of Circulation. Data from and access to third party social media platforms, including but not limited to Facebook, Twitter, Instagram and others, is subject to the

n people." Pfizer's COVID Vaccine Trial On Track To Beat Rivals. Bloomberg (9/22, Langreth, 4.73M) reports, "The Covid-19 vaccine trial designed by Pfizer Inc. and its German partner BioNTech SE may allow them to find whether their shot works before their fastest-moving rivals." The firms "plan a first loo

dditional forms of open-source data. Sources for Bulletin Intelligence audience-size estimates include Scarborough, GfK MRI, comScore, Nielsen, and the Audit Bureau of Circulation. Data from and access to third party social media platforms, including but not limited to Facebook, Twitter, Instagram and others, is subject to the

starting Monday." Bloomberg adds that according to Mkhize, "the government will start a mass vaccination effort at 87 sites across the country using Pfizer Inc. doses administered to frontline health-care workers and the elderly." Pandemic Leading To Refugee Waves Across World. The New York Times (5/16, Jo

dditional forms of open-source data. Sources for Bulletin Intelligence audience-size estimates include Scarborough, GfK MRI, comScore, Nielsen, and the Audit Bureau of Circulation. Data from and access to third party social media platforms, including but not limited to Facebook, Twitter, Instagram and others, is subject to the

n people." Pfizer's COVID Vaccine Trial On Track To Beat Rivals. Bloomberg (9/22, Langreth, 4.73M) reports, "The Covid-19 vaccine trial designed by Pfizer Inc. and its German partner BioNTech SE may allow them to find whether their shot works before their fastest-moving rivals." The firms "plan a first loo

dditional forms of open-source data. Sources for Bulletin Intelligence audience-size estimates include Scarborough, GfK MRI, comScore, Nielsen, and the Audit Bureau of Circulation. Data from and access to third party social media platforms, including but not limited to Facebook, Twitter, Instagram and others, is subject to the

e Trial Ready To Analyze Shot's Effectiveness. Bloomberg (11/11, Langreth, 4.73M) reports that the "same US explosion of Covid-19 cases that helped Pfizer Inc. get results for its vaccine trial earlier this week is helping speed along Moderna's trial." Moderna "said Wednesday its study has accumulated more

additional forms of open-source data. Sources for Bulletin Intelligence audience-size estimates include Scarborough, OR MRI, comScore, Nielsen, and the Audit Bureau of Circulation. Data from and access to third party social media platforms, including but not limited to Facebook, Twitter, Instagram and others, is subject to the